Evidence map›Paper›PMID 37665023›Full record

ArticleAlcohol and alcoholism (Oxford, Oxfordshire)2024

The adolescent and young adult microbiome and its association with substance use: a scoping review.

Brittney D Browning, Anna E Kirkland, Rejoyce Green, Melinda Engevik, Alexander V Alekseyenko, Lorenzo Leggio, Rachel L Tomko, Lindsay M Squeglia

Open access · bronzeAbstract readScoping Review
In one paragraph

Article in Alcohol and alcoholism (Oxford, Oxfordshire), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
  5. Acquisition of the Oral Microbiome.Advances in experimental medicine and biology · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brittney D BrowningDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President St., Charleston, SC 29425, United States.ORCID 0000-0002-9868-0440
Anna E KirklandDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President St., Charleston, SC 29425, United States.
Rejoyce GreenDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President St., Charleston, SC 29425, United States.
Melinda EngevikDepartment of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Ave., Charleston SC, 29425, United States.
Alexander V AlekseyenkoDepartment of Public Health Sciences, Biomedical Informatics Center, Medical University of South Carolina, 135 Cannon St., Charleston, SC 29425, United States.
Lorenzo LeggioClinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore, Maryland, USA.
Rachel L TomkoDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President St., Charleston, SC 29425, United States.
Lindsay M SquegliaDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President St., Charleston, SC 29425, United States.
Medical University of South Carolina · USNational Institute on Drug Abuse · US

Funding

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)ZIADA000635 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI LEGGIO, LORENZO · 2020 to 2025
$15.2M
Mentoring Clinical Investigators in Patient-Oriented Adolescent Alcohol ResearchK24AA031052 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Lindsay Squeglia · 2024 to 2026
$644k
Utilizing multimodal neuroimaging to identify neurometabolic and neurobehavioral correlates of adolescent binge drinkingF32AA029930 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KIRKLAND, ANNA E · 2022 to 2023
$101k
Examining Associations between the Oral Microbiota, Neuroinflammation, and Binge Drinking in AdolescentsF31AA030920 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BROWNING, BRITTNEY · 2023 to 2023
$45k
NIAAA NIH HHS F31 AA030920NIAAA NIH HHS F32 AA029930NIAAA NIH HHS K24 AA031052
6 · The paper itself

Abstract

aimsThe microbiome is a critical factor in health throughout human development. The aims of this scoping review are to (i) elucidate the differences between the youth (post-natal day 21-65 for rodents, 2-7 years for non-human primates, and 10-25 years for humans) microbiome with other life stages and (ii) identify youth-specific microbial changes associated with substance use.

methodsPeer-reviewed studies published up to May 2023 were identified in PubMed and SCOPUS and included gut and oral microbiome studies from rodents, non-human primates, and humans (N = 1733). Twenty-six articles were determined eligible based on inclusion criteria (aim 1: n = 19, aim 2: n = 7).

resultsThe adolescent and young adult oral and gut microbiomes are distinct compared to other life stages, within both non-human and human models. While there is limited research in this area, the microbiome appears to be vulnerable to substance use exposure earlier in life, including substances commonly initiated and escalated during adolescence and young adulthood (i.e. alcohol, cannabis, and tobacco).

conclusionsStudies across the lifespan indicate that adolescence and young adulthood are distinct periods of development, where the microbiome is sensitive to exposures, including substance use. There is a need for more studies focused on the adolescent and young adult microbiome and substance use, as well as focused on the oral microbiome during this developmental period. Understanding the gut and oral microbiome during adolescence and young adulthood may provide insight into the pathophysiology of substance use disorders.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaSubstance-Related DisordersAdolescentAdultAnimalsHumansPrimatesYoung Adultadolescencedevelopmentgutmicrobiomeoralsubstances

Identifiers

PMID37665023
PMCPMC10979412
OpenAlexW4386407137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.